Psilocybin as Transformative Fast‐Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70038
- By:
- Publication type:
- Article
Works matching IS 07673981 AND DT 2025 AND VI 39 AND IP 4
Results: 16
1
2
Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70037
- By:
- Publication type:
- Article
3
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70036
- By:
- Publication type:
- Article
4
DPD Ultra‐Rapid Metabolizer Status and Efficacy of 5‐Fluorouracil Treatment: A Real‐World Study.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70035
- By:
- Publication type:
- Article
5
Effects of FECH Gene Polymorphisms and Serum Ferrochelatase Levels on Antituberculosis Drug‐Induced Liver Injury in China.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70034
- By:
- Publication type:
- Article
6
Differential Effects of Prenatal Poly I:C Exposure and Antipsychotics on NMDA/GABA Receptors and GSK3β‐Mediated Signaling in the Dorsal Raphe Nucleus of Female Rats.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70033
- By:
- Publication type:
- Article
7
Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70031
- By:
- Publication type:
- Article
8
Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70030
- By:
- Publication type:
- Article
9
Hydrogen Sulfide Treatment Enhanced Paclitaxel's Anticancer Effect on the ID8 Murine Epithelial Ovarian Cancer Cell Line.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70029
- By:
- Publication type:
- Article
10
Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70028
- By:
- Publication type:
- Article
11
Relapse and New‐Onset of Autoimmune or Inflammatory Diseases Following Vaccination With SPIKEVAX: Pharmacovigilance Overview From the French Spontaneous Reported System.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70027
- By:
- Publication type:
- Article
12
Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70026
- By:
- Publication type:
- Article
13
Angiotensin II Type 1 Receptor Blocker Usage Prevents Oxidative Stress and Muscle Dysfunction in HIV.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70016
- By:
- Publication type:
- Article
14
Fundamental and clinical pharmacology for a new psychiatry.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70015
- By:
- Publication type:
- Article
15
Vitamin D lacks efficacy: A re‐analysis of a systematic review using the REB method.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.70011
- By:
- Publication type:
- Article
16
Issue Information.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 4, p. 1, doi. 10.1111/fcp.13056
- Publication type:
- Article